Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study.

Esther Vanderstuyft Julie Hias Laura HellemansLucas Van AelstJos TournoyLorenz Roger Van der Linden

Published in: European journal of hospital pharmacy : science and practice (2024)

Most geriatric inpatients received a justified reduced DOAC dose. A significant proportion was managed inappropriately with underdosing (= unjustified reduced dose) being most common. Frequently no rationale was provided for deviating from trial-tested doses.

Keyphrases

atrial fibrillation
direct oral anticoagulants
clinical trial
hip fracture
study protocol
heart failure
catheter ablation
venous thromboembolism
oral anticoagulants
randomized controlled trial
percutaneous coronary intervention
coronary artery disease
acute coronary syndrome
open label
double blind